| Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence RK Vaddepally, P Kharel, R Pandey, R Garje, AB Chandra Cancers 12 (3), 738, 2020 | 1052 | 2020 |
| Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy V Kumar, N Chaudhary, M Garg, CS Floudas, P Soni, AB Chandra Frontiers in pharmacology 8, 49, 2017 | 607 | 2017 |
| Immunohistochemical analysis of steroid sulfatase in human tissues KW Selcer, HM DiFrancesca, AB Chandra, PK Li The Journal of steroid biochemistry and molecular biology 105 (1-5), 115-123, 2007 | 44 | 2007 |
| Cardiac tamponade caused by fracture and migration of inferior vena cava filter. PA Chandra, C Nwokolo, D Chuprun, AB Chandra Southern medical journal 101 (11), 1163-1164, 2008 | 35 | 2008 |
| Tako-tsubo cardiomyopathy following electroconvulsive therapy PA Chandra, G Golduber, D Chuprun, AB Chandra Journal of Cardiovascular Medicine 10 (4), 333-335, 2009 | 31 | 2009 |
| A comparative study of primary adenoid cystic and mucoepidermoid carcinoma of lung V Kumar, P Soni, M Garg, A Goyal, T Meghal, S Kamholz, AB Chandra Frontiers in Oncology 8, 153, 2018 | 29 | 2018 |
| Chemotherapy induced Takotsubo cardiomyopathy S Goel, A Sharma, A Garg, A Chandra, V Shetty World Journal of Clinical Cases: WJCC 2 (10), 565, 2014 | 29 | 2014 |
| Emerging therapies in the management of advanced-stage gastric cancer V Kumar, P Soni, M Garg, S Kamholz, AB Chandra Frontiers in Pharmacology 9, 344870, 2018 | 28 | 2018 |
| Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge R Vaddepally, R Doddamani, S Sodavarapu, NR Madam, R Katkar, ... Biomedicines 10 (4), 790, 2022 | 27 | 2022 |
| Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival CS Floudas, AB Chandra, Y Xu Melanoma research 26 (3), 312-315, 2016 | 25 | 2016 |
| Primary renal lymphoma: A population‐based analysis using the SEER program (1973‐2015) A Taneja, V Kumar, AB Chandra European Journal of Haematology 104 (5), 390-399, 2020 | 21 | 2020 |
| Bortezomib-induced pulmonary toxicity: a case report and review of literature P Kharel, D Uprety, AB Chandra, Y Hu, AA Belur, A Dhakal Case Reports in Medicine 2018, 2018 | 19 | 2018 |
| An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States V Kumar, M Garg, N Chaudhary, AB Chandra PeerJ 6, e4342, 2018 | 19 | 2018 |
| Brugada syndrome unmasked by lithium. PA Chandra, AB Chandra Southern medical journal 102 (12), 1263-1265, 2009 | 16 | 2009 |
| Racial disparities in incidence & survival of Kaposi's sarcoma in the United States V Kumar, P Soni, M Garg, AT Hashmi, AB Chandra Indian Journal of Medical Research 149 (3), 354-363, 2019 | 13 | 2019 |
| Trends in the risks of secondary cancers in patients with Hodgkin lymphoma V Kumar, M Garg, AB Chandra, VS Mayorga, S Ahmed, S Ailawadhi Clinical Lymphoma Myeloma and Leukemia 18 (9), 576-589. e1, 2018 | 13 | 2018 |
| Protothecal olecranon bursitis: an unusual algal infection M Pednekar, PA Chandra, AB Chandra, Y Margulis, C Schiff The American journal of the medical sciences 342 (5), 424, 2011 | 12 | 2011 |
| A comparison between two types of indwelling pleural catheters for management of malignant pleural effusions SS Gupta, CS Floudas, AB Chandra Journal of Thoracic Disease 10 (5), 2976, 2018 | 9 | 2018 |
| Recurrent arterial thrombosis as a presenting feature of a variant M3-acute promyelocytic leukemia PN Chotai, K Kasangana, AB Chandra, AS Rao Vascular Specialist International 32 (2), 65, 2016 | 8 | 2016 |
| Aplastic anemia-A quick review P Singh, A Sinha, A Kamath, S Malhotra, AB Chandra J Cancer Prev Curr Res 7 (5), 1-6, 2017 | 7 | 2017 |
